Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Conventional MRI scan and DTI imaging show more severe brain injury in neonates with hypoxic-ischemic encephalopathy and seizures.

Kline-Fath BM, Horn PS, Yuan W, Merhar S, Venkatesan C, Thomas CW, Schapiro MB.

Early Hum Dev. 2018 Jul;122:8-14. doi: 10.1016/j.earlhumdev.2018.05.008. Epub 2018 May 24.

PMID:
29803998
2.

Child Neurology: Two sisters with dystonia and regression: PLA2G6-associated neurodegeneration.

Blake RB, Gilbert DL, Schapiro MB.

Neurology. 2016 Jul 5;87(1):e1-3. doi: 10.1212/WNL.0000000000002804. No abstract available.

3.

Functional magnetic resonance imaging of story listening in adolescents and young adults with Down syndrome: evidence for atypical neurodevelopment.

Jacola LM, Byars AW, Hickey F, Vannest J, Holland SK, Schapiro MB.

J Intellect Disabil Res. 2014 Oct;58(10):892-902. doi: 10.1111/jir.12089. Epub 2013 Aug 20.

PMID:
23962356
4.

Child neurology: hemiconvulsion-hemiplegia-epilepsy syndrome.

Tenney JR, Schapiro MB.

Neurology. 2012 Jul 3;79(1):e1-4. doi: 10.1212/WNL.0b013e31825dce5f. Review.

PMID:
22753451
5.

Left-handedness and language lateralization in children.

Szaflarski JP, Rajagopal A, Altaye M, Byars AW, Jacola L, Schmithorst VJ, Schapiro MB, Plante E, Holland SK.

Brain Res. 2012 Jan 18;1433:85-97. doi: 10.1016/j.brainres.2011.11.026. Epub 2011 Nov 28.

6.

Functional magnetic resonance imaging of cognitive processing in young adults with Down syndrome.

Jacola LM, Byars AW, Chalfonte-Evans M, Schmithorst VJ, Hickey F, Patterson B, Hotze S, Vannest J, Chiu CY, Holland SK, Schapiro MB.

Am J Intellect Dev Disabil. 2011 Sep;116(5):344-59. doi: 10.1352/1944-7558-116.5.344.

PMID:
21905803
7.

Deletion of 14-3-3{varepsilon} and CRK: a clinical syndrome with macrocephaly, developmental delay, and generalized epilepsy.

Tenney JR, Hopkin RJ, Schapiro MB.

J Child Neurol. 2011 Feb;26(2):223-7. doi: 10.1177/0883073810379638. Epub 2010 Sep 10.

PMID:
20833799
8.

Child neurology: alternating hemiplegia of childhood.

Tenney JR, Schapiro MB.

Neurology. 2010 Apr 6;74(14):e57-9. doi: 10.1212/WNL.0b013e3181d7d85b. No abstract available.

PMID:
20368625
9.

Cholinergic modulation of visual working memory during aging: a parametric PET study.

Ricciardi E, Pietrini P, Schapiro MB, Rapoport SI, Furey ML.

Brain Res Bull. 2009 Jun 30;79(5):322-32. doi: 10.1016/j.brainresbull.2009.01.013. Epub 2009 Feb 7.

10.

Reprint of "Cortical reorganization of language functioning following perinatal left MCA stroke" [Brain and Language 105 (2008) 99-111].

Tillema JM, Byars AW, Jacola LM, Schapiro MB, Schmithorst VJ, Szaflarski JP, Holland SK.

Brain Lang. 2008 Sep;106(3):184-94. doi: 10.1016/j.bandl.2008.08.001.

PMID:
18762059
11.

Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory.

Furey ML, Ricciardi E, Schapiro MB, Rapoport SI, Pietrini P.

J Cogn Neurosci. 2008 Jul;20(7):1342-53. doi: 10.1162/jocn.2008.20092.

12.

Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21.

Miles MV, Patterson BJ, Chalfonte-Evans ML, Horn PS, Hickey FJ, Schapiro MB, Steele PE, Tang PH, Hotze SL.

Pediatr Neurol. 2007 Dec;37(6):398-403.

PMID:
18021919
13.

Cortical reorganization of language functioning following perinatal left MCA stroke.

Tillema JM, Byars AW, Jacola LM, Schapiro MB, Schmithorst VJ, Szaflarski JP, Holland SK.

Brain Lang. 2008 May;105(2):99-111. Epub 2007 Oct 1.

14.

Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial.

Miles MV, Patterson BJ, Schapiro MB, Hickey FJ, Chalfonte-Evans M, Horn PS, Hotze SL.

Pediatr Neurol. 2006 Jul;35(1):30-7.

PMID:
16814082
15.

Functional magnetic resonance imaging reveals atypical language organization in children following perinatal left middle cerebral artery stroke.

Jacola LM, Schapiro MB, Schmithorst VJ, Byars AW, Strawsburg RH, Szaflarski JP, Plante E, Holland SK.

Neuropediatrics. 2006 Feb;37(1):46-52.

16.

Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine.

Freo U, Ricciardi E, Pietrini P, Schapiro MB, Rapoport SI, Furey ML.

Am J Psychiatry. 2005 Nov;162(11):2061-70.

PMID:
16263845
17.

Brain MRI and proton MRS findings in infants and children with respiratory chain defects.

Dinopoulos A, Cecil KM, Schapiro MB, Papadimitriou A, Hadjigeorgiou GM, Wong B, deGrauw T, Egelhoff JC.

Neuropediatrics. 2005 Oct;36(5):290-301.

PMID:
16217703
18.

BOLD fMRI signal increases with age in selected brain regions in children.

Schapiro MB, Schmithorst VJ, Wilke M, Byars AW, Strawsburg RH, Holland SK.

Neuroreport. 2004 Dec 3;15(17):2575-8.

19.

Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome.

Tang Y, Schapiro MB, Franz DN, Patterson BJ, Hickey FJ, Schorry EK, Hopkin RJ, Wylie M, Narayan T, Glauser TA, Gilbert DL, Hershey AD, Sharp FR.

Ann Neurol. 2004 Dec;56(6):808-14.

PMID:
15562430
20.

Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.

Rapoport SI, Schapiro MB, May C.

Arch Neurol. 2004 Nov;61(11):1721-4.

PMID:
15534183
21.

Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy.

Ibáñez V, Pietrini P, Furey ML, Alexander GE, Millet P, Bokde AL, Teichberg D, Schapiro MB, Horwitz B, Rapoport SI.

Brain Res Bull. 2004 Mar 15;63(2):147-54.

PMID:
15130704
22.

Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.

Teipel SJ, Alexander GE, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.

Brain. 2004 Apr;127(Pt 4):811-24. Epub 2004 Feb 25.

PMID:
14985261
23.

Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.

Teipel SJ, Schapiro MB, Alexander GE, Krasuski JS, Horwitz B, Hoehne C, Möller HJ, Rapoport SI, Hampel H.

Am J Psychiatry. 2003 Oct;160(10):1870-8.

PMID:
14514503
24.

Congenital creatine transporter deficiency.

deGrauw TJ, Salomons GS, Cecil KM, Chuck G, Newmeyer A, Schapiro MB, Jakobs C.

Neuropediatrics. 2002 Oct;33(5):232-8.

PMID:
12536364
25.

Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.

Teipel SJ, Bayer W, Alexander GE, Bokde AL, Zebuhr Y, Teichberg D, Müller-Spahn F, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.

Neurobiol Aging. 2003 Jan-Feb;24(1):85-94.

PMID:
12493554
26.

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H.

Arch Neurol. 2002 Aug;59(8):1267-72.

PMID:
12164722
27.

Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF.

Atack JR, Schapiro MB.

Neurobiol Aging. 2002 May-Jun;23(3):389-96.

PMID:
11959401
28.

Progression of corpus callosum atrophy in Alzheimer disease.

Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.

Arch Neurol. 2002 Feb;59(2):243-8.

PMID:
11843695
29.

Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease.

Hampel H, Teipel SJ, Bayer W, Alexander GE, Schwarz R, Schapiro MB, Rapoport SI, Möller HJ.

J Neurol Sci. 2002 Feb 15;194(1):15-9.

PMID:
11809161
30.
31.

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME.

JAMA. 2001 Nov 7;286(17):2120-7.

PMID:
11694153
32.

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.

Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB.

Neurology. 2001 Aug 28;57(4):626-32.

PMID:
11524470
33.

The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.

Bokde AL, Pietrini P, Ibáñez V, Furey ML, Alexander GE, Graff-Radford NR, Rapoport SI, Schapiro MB, Horwitz B.

Arch Neurol. 2001 Mar;58(3):480-6.

PMID:
11255453
34.

Age-related differences in visual perception: a PET study.

Levine BK, Beason-Held LL, Purpura KP, Aronchick DM, Optican LM, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB.

Neurobiol Aging. 2000 Jul-Aug;21(4):577-84.

PMID:
10924775
35.

Time course of pharmacodynamic and pharmacokinetic effects of physostigmine assessed by functional brain imaging in humans.

Furey ML, Pietrini P, Alexander GE, Mentis MJ, Szczepanik J, Shetty U, Greig NH, Holloway HW, Schapiro MB, Freo U.

Pharmacol Biochem Behav. 2000 Jul;66(3):475-81.

PMID:
10899358
36.

Phospholipid composition and levels are altered in Down syndrome brain.

Murphy EJ, Schapiro MB, Rapoport SI, Shetty HU.

Brain Res. 2000 Jun 9;867(1-2):9-18.

PMID:
10837793
37.

Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease.

Hampel H, Teipel SJ, Alexander GE, Horwitz B, Pietrini P, Hippius H, Möller HJ, Schapiro MB, Rapoport SI.

Ann N Y Acad Sci. 2000 Apr;903:470-6. No abstract available.

PMID:
10818540
39.

Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment.

Huang W, Galdzicki Z, van Gelderen P, Balbo A, Chikhale EG, Schapiro MB, Rapoport SI.

Neuroreport. 2000 Feb 28;11(3):445-8.

PMID:
10718292
40.

High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.

Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB.

Am J Psychiatry. 1999 Dec;156(12):1879-86.

PMID:
10588400
41.

Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism.

Murphy DG, Mentis MJ, Pietrini P, Grady CL, Moore CJ, Horwitz B, Hinton V, Dobkin CS, Schapiro MB, Rapoport SI.

J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1294-301.

PMID:
10517063
42.

Individual differences in PET activation of object perception and attention systems predict face matching accuracy.

Alexander GE, Mentis MJ, Van Horn JD, Grady CL, Berman KF, Furey ML, Pietrini P, Rapoport SI, Schapiro MB, Moeller JR.

Neuroreport. 1999 Jun 23;10(9):1965-71.

PMID:
10501542
43.

Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease.

Asthana S, Raffaele KC, Greig NH, Schapiro MB, Blackman MR, Soncrant TT.

Alzheimer Dis Assoc Disord. 1999 Apr-Jun;13(2):102-8.

PMID:
10372954
44.

Regional cerebral blood flow in Down syndrome adults during the Wisconsin Card Sorting Test: exploring cognitive activation in the context of poor performance.

Schapiro MB, Berman KF, Alexander GE, Weinberger DR, Rapoport SI.

Biol Psychiatry. 1999 May 1;45(9):1190-6.

PMID:
10331111
45.

Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.

Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, Möller HJ, Schapiro MB, Rapoport SI.

Arch Neurol. 1999 Apr;56(4):467-73.

PMID:
10199337
46.

Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.

Pietrini P, Furey ML, Alexander GE, Mentis MJ, Dani A, Guazzelli M, Rapoport SI, Schapiro MB.

Am J Psychiatry. 1999 Mar;156(3):470-3.

PMID:
10080567
47.

Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease.

Teipel SJ, Hampel H, Alexander GE, Schapiro MB, Horwitz B, Teichberg D, Daley E, Hippius H, Möller HJ, Rapoport SI.

Neurology. 1998 Nov;51(5):1381-5.

PMID:
9818864
48.

Effect of DNA repair inhibitors on the in vitro test for Alzheimer's disease.

Parshad R, Price FM, Schapiro MB, Sanford KK.

J Am Geriatr Soc. 1998 Oct;46(10):1331-3. No abstract available.

PMID:
9777930
49.

Cortical regions involved in visual texture perception: a fMRI study.

Beason-Held LL, Purpura KP, Krasuski JS, Maisog JM, Daly EM, Mangot DJ, Desmond RE, Optican LM, Schapiro MB, VanMeter JW.

Brain Res Cogn Brain Res. 1998 Oct;7(2):111-8.

PMID:
9774714
50.

Role of familial factors in late-onset Alzheimer disease as a function of age.

Wu Z, Kinslow C, Pettigrew KD, Rapoport SI, Schapiro MB.

Alzheimer Dis Assoc Disord. 1998 Sep;12(3):190-7.

PMID:
9772022

Supplemental Content

Loading ...
Support Center